Plain-English translation of NCT06267508 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is testing a new approach to prevent serious illness in newborns born to mothers with HIV. The goal is to identify HIV infection in babies as early as possible—even at birth—and start treatment right away. Researchers believe that catching and treating the infection early may reduce the risk of infant death and severe disease.
While the number of children born with HIV has dropped by more than half over the past decade, progress has slowed. Past research showed that testing newborns immediately and starting this treatment early is possible and promising, but challenges like difficulty giving the medication to infants and trouble keeping mothers connected to care led to poor results. This study aims to solve those problems and make early testing and treatment available to more families, especially in rural areas.
You likely qualify if…
You likely don't qualify if…
If you join this study, you and your newborn will receive HIV testing, counseling, and early treatment if needed. You'll have regular visits with the study team to monitor your baby's health and check how well the treatment is working. The study includes support from healthcare workers and electronic tools to help share your results between clinics, and the research team will work with you to remove barriers to staying in care. Follow-up continues for up to 12 months if your baby is found to have HIV.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Mozambique
Tanzania